Remifentanil effect on shoulder surgery postoperative pain

Clinical trial on incremental and low dose remifentanil effect on acute postoperative pain in recovery room after shoulder surgeries

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017050126328N4

Enrollment

Registered

2017-06-06

Start date

2017-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder fracture postoperative pain. Dislocation, sprain and strain of joints and ligaments of shoulder girdle

Interventions

Intervention 1: Intervention group: Diluted remifentanil solution including 10 micrograms per milliliter will be infused 1 milliliter each 20 minutes, till complete analgesia onset. Intervention 2: Co

Treatment - Drugs

Intervention group: Diluted remifentanil solution including 10 micrograms per milliliter will be infused 1 milliliter each 20 minutes, till complete analgesia onset.

Control group: 0.1 milligram per kilogram morphine will be administered in divided doses, till complete analgesia onset.

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients candidate to undergo shoulder surgery; aged between 20 and 60 years old; Class I or II according to ASA classification. Exclusion criteria: history of uncontrollable chronic pain; history of allergy to analgesics; history of psychotropic drugs consumption; recent use of analgesics; operation time more than 2 hours; pregnant and breastfeeding women.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Duration of analegsia onset. Timepoint: Postoperative recovery. Method of measurement: Questionnaire.;Patients pain severity after shoulder surgery during recovery. Timepoint: In admission to recovery room and discharge from the recovery. Method of measurement: Using visual analogue scale.	—

Secondary

Measure	Time frame
Administered remifentanil dosage amount. Timepoint: During admission to recovery. Method of measurement: Questionnaire.;Nausea and vomiting due to remifentanil injection. Timepoint: During admission to recovery. Method of measurement: Questionnaire.;Hypotension due to remifentanil injection. Timepoint: During admission to recovery. Method of measurement: Questionnaire.;Bradycardia due to remifentanil injection. Timepoint: During admission to recovery. Method of measurement: Questionnaire.	—

Measure

Time frame

Administered remifentanil dosage amount. Timepoint: During admission to recovery. Method of measurement: Questionnaire.;Nausea and vomiting due to remifentanil injection. Timepoint: During admission to recovery. Method of measurement: Questionnaire.;Hypotension due to remifentanil injection. Timepoint: During admission to recovery. Method of measurement: Questionnaire.;Bradycardia due to remifentanil injection. Timepoint: During admission to recovery. Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masoud Parish

Tabriz University of Medical Sciences

parsihm@tbzmed.ac.ir+98 41 3385 5842

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026